Absci ($ABSI) Insider Trading & Smart Money Activity

Absci Corporation · Biotechnology · Latest filing Jun 25, 2026

Absci Corporation ($ABSI) has 1 insider trade, 6 13F position changes and 4 analyst ratings on file. Insiders filed 1 Form 4 transaction in the last 12 months, none of them open-market purchases or sales.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
0
Net insider $ (12 mo)
$0
Congress trades (12 mo)
0
13F moves on file
6
Analyst ratings on file
4

ABSI insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 0 0 / 0 6 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All ABSI insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Analyst HC Wainwright Reiterates to buy PT $16 +13.8%-26.0% Read
Analyst Needham Reiterates to buy PT $11 +10.3%-24.9% Read
Insider Sean McclainChief Executive Officer Sell (Tax withholding) 59.90K sh $603.75K +10.3%-24.9% Read
Analyst BTIG Reiterates to buy PT $13 +10.3%-24.9% Read
Analyst Guggenheim Reiterates to buy PT $15 +15.5%+34.3% Read
13F Susquehanna International Group Added +223.97K sh $7.41M -0.6%+41.7% Read
13F Simplex Trading New +227.04K sh $1.48M -8.1%+31.2% —
13F Simplex Trading New +227.04K sh $2.53M -8.1%+31.2% —
13F Group One Trading New +1.13M sh $7.37M -6.6%+28.3% —
13F Group One Trading New +1.13M sh $12.62M -6.6%+28.3% —
13F ARK Investment Management Added +1.18M sh $153.05M -13.6%+21.5% —

1W / 1M / 6M = how ABSI moved from the trade or filing date.

Insider trading in ABSI: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Sean Mcclain Chief Executive Officer 1 — Jun 24, 2026

Institutions moving ABSI (13F)

Analyst ratings on ABSI

DateFirmActionRatingPrice target1W1M6MStory
HC Wainwright Reiterates buy $16 +13.8%-26.0% Read
Needham Reiterates buy $11 +10.3%-24.9% Read
BTIG Reiterates buy $13 +10.3%-24.9% Read
Guggenheim Reiterates buy $15 +15.5%+34.3% Read

Frequently asked questions

What is the latest insider trade in ABSI?

Sean Mcclain, Chief Executive Officer filed a sell (tax withholding) of 59.90K sh worth $603.75K on Jun 24, 2026.

Which institutions changed their ABSI positions?

Recent 13F filers moving the stock include Simplex Trading, Group One Trading, Susquehanna International Group and ARK Investment Management.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text